Pharmacokinetics, Metabolism, and Saliva Output During Transdermal and Extended-Release Oral Oxybutynin Administration in Healthy Subjects

This publication has 20 references indexed in Scilit:

• Pharmacokinetics and Metabolism of Transdermal Oxybutynin: In Vitro and in Vivo Performance of a Novel Delivery System
  Pharmaceutical Research, 2003
• Efficacy and Safety of Transdermal Oxybutynin in Patients With Urge and Mixed Urinary Incontinence
  Journal of Urology, 2002
• Pharmacokinetics, Efficacy, and Safety of Intravesical Formulation of Oxybutynin in Patients with Detrusor Overactivity
  Scandinavian Journal of Urology and Nephrology, 2002
• Effect of OROS^®controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride
  Published by Wiley ,2001
• A SHORT-TERM, MULTICENTER, RANDOMIZED DOUBLE-BLIND DOSE TITRATION STUDY OF THE EFFICACY AND ANTICHOLINERGIC SIDE EFFECTS OF TRANSDERMAL COMPARED TO IMMEDIATE RELEASE ORAL OXYBUTYNIN TREATMENT OF PATIENTS WITH URGE URINARY INCONTINENCE
  Journal of Urology, 2001
• A comparison of the effects of saliva output of oxybutynin chloride and tolterodine tartrate
  Clinical Therapeutics, 2001
• Comparison of Oxybutynin and its Active Metabolite, N-Desethyl-Oxybutynin, in the Human Detrusor and Parotid Gland
  Journal of Urology, 1997
• Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride
  Spinal Cord, 1991
• Oxybutynin Hydrochloride (3 mg) in the Treatment of Women with Idiopathic Detrusor Instability
  British Journal of Urology, 1990
• The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled study
  BJOG: An International Journal of Obstetrics and Gynaecology, 1990